Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 9.11
-0.52 (-5.40%)
Sep 10, 2026, 12:44 PM CST
SHE:002412 Revenue
Hunan Hansen Pharmaceutical had revenue of 212.94M CNY in the quarter ending June 30, 2026, a decrease of -11.11%. This brings the company's revenue in the last twelve months to 1.01B, down -2.59% year-over-year. In the year 2025, Hunan Hansen Pharmaceutical had annual revenue of 1.04B with 3.41% growth.
Revenue (ttm)
1.01B
Revenue Growth
-2.59%
P/S Ratio
4.82
Revenue / Employee
477.27K
Employees
2,108
Market Cap
4.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.04B | 34.29M | 3.41% |
| Dec 31, 2024 | 1.00B | 48.94M | 5.12% |
| Dec 31, 2023 | 955.53M | 39.47M | 4.31% |
| Jan 1, 2023 | 916.06M | 24.23M | 2.72% |
| Jan 1, 2022 | 891.84M | 150.60M | 20.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.